Document is current
Any future updates will be listed below
-
Authors
Oyesola, Oyebola https://orcid.org/0000-0002-5347-7502
Downie, Alexander E. https://orcid.org/0000-0002-6743-620X
Howard, Nina https://orcid.org/0000-0002-1204-5885
Barre, Ramya S. https://orcid.org/0000-0002-8773-6349
Kiwanuka, Kasalina
Zaldana, Kimberly
Chen, Ying-Han https://orcid.org/0000-0002-6720-8610
Menezes, Arthur https://orcid.org/0000-0002-0195-4071
Lee, Soo Ching https://orcid.org/0000-0002-5454-2265
Devlin, Joseph
Mondragón-Palomino, Octavio
Souza, Camila Oliveira Silva https://orcid.org/0000-0002-6922-5270
Herrmann, Christin
Koralov, Sergei B.
Cadwell, Ken https://orcid.org/0000-0002-5860-0661
Graham, Andrea L. https://orcid.org/0000-0002-6580-2755
Loke, P’ng https://orcid.org/0000-0002-6211-3292
- License Information
-
More Information
Article History
Received: 2 May 2023
Accepted: 2 May 2024
First Online: 14 June 2024
Competing interests
: K.C. has received research funding from Pfizer, Takeda, Pacific Biosciences, Genentech and Abbvie, and P.L. has received research funding from Pfizer. K.C. has consulted for or received an honorarium from Puretech Health, Genentech and Abbvie. K.C. is an inventor on US patent 10,722,600 and provisional patents 62/935,035 and 63/157,225. S.B.K. acknowledges funding from Micreos and KymeraTx in the past 3 years. P.L. and O.O. are federal employees. The other authors declare no competing interests.
